Reimagining U.S. Drug Policy Post-Pandemic

Ohio State Legal Studies Research Paper No. 684

Drug Enforcement and Policy Center, No. 43, February 2022

10 Pages Posted: 22 Feb 2022 Last revised: 1 Mar 2022

See all articles by Samuel DeWitt

Samuel DeWitt

Ohio State University (OSU), Michael E. Moritz College of Law

Date Written: February 17, 2022

Abstract

The COVID-19 pandemic caused increased drug use and a widespread decline in mental health throughout American society. Yet, despite the unprecedented pandemic, society as a whole has shown an impressive ability to adapt to new ways of living, suggesting that a dramatically different version of America is not only possible, but achievable. Domestic drug policy, which has needlessly prohibited and criminalized a vast array of drugs since the early 1900s, is an area ripe for a similar dramatic change. This paper explores how the pandemic, combined with concurrent events including a change in Federal Administration and nationwide protests against systemic racism, presents an opportunity for our country to rethink its long-standing drug prohibition on a national scale.

Keywords: COVID, pandemic, drugs, drug policy, protests, legalization, War on Drugs

Suggested Citation

DeWitt, Samuel, Reimagining U.S. Drug Policy Post-Pandemic (February 17, 2022). Ohio State Legal Studies Research Paper No. 684, Drug Enforcement and Policy Center, No. 43, February 2022, Available at SSRN: https://ssrn.com/abstract=4037600 or http://dx.doi.org/10.2139/ssrn.4037600

Samuel DeWitt (Contact Author)

Ohio State University (OSU), Michael E. Moritz College of Law ( email )

55 West 12th Avenue
Columbus, OH 43210
United States

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Downloads
156
Abstract Views
814
Rank
375,409
PlumX Metrics